Holley projects 2025 revenue between $590M and $605M, focusing on margin growth and debt reduction.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 07 2025
0mins
Source: SeekingAlpha
Management Insights: Holley Inc. reported a strong Q3 2025 with a 6.4% core business growth, emphasizing their omnichannel strategy and significant progress in B2B channels, alongside improved free cash flow and reduced debt leverage.
Financial Performance: The company achieved net sales of $138.4 million, a gross margin of 43.2%, and an adjusted EBITDA margin of 19.6%, marking improvements in profitability and operational metrics compared to the previous year.
Updated Guidance: Management raised revenue expectations for 2025 to a range of $590 million to $605 million, reflecting increased confidence in their ability to navigate macroeconomic conditions and sustain growth.
Risks and Concerns: Ongoing risks include inflation and macroeconomic uncertainty, with analysts expressing caution regarding potential sales deceleration and inventory management, while management remains focused on operational discipline and strategic execution.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HLLY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HLLY
Wall Street analysts forecast HLLY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLLY is 5.25 USD with a low forecast of 4.50 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 3.930
Low
4.50
Averages
5.25
High
7.00
Current: 3.930
Low
4.50
Averages
5.25
High
7.00
About HLLY
Holley, Inc. is engaged in the design, manufacturing and marketing of high-performance products for automotive enthusiasts. The Company owns and manages a portfolio of brands, catering to a diverse community of enthusiasts passionate about the customization and performance of their vehicles. It is a manufacturer of a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It is also a manufacturer of exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The Company’s products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. Its brands include Holley EFI, Holley, MSD, Simpson, and Flowmaster, among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cytokinetics Faces Shareholder Claims Over Executive Misconduct, Potential for Corporate Reforms
- Shareholder Claims Investigation: Grabar Law Office is investigating whether Cytokinetics' executives breached their fiduciary duties, allowing shareholders who purchased shares before December 27, 2023, to seek corporate reforms and fund recovery.
- FDA Review Delays: Cytokinetics acknowledged in May 2025 that it failed to include a Risk Evaluation and Mitigation Strategy in its New Drug Application, resulting in the FDA extending the review date from September 2025 to December 2025, which negatively impacted the company's reputation and shareholder confidence.
- False Statement Allegations: A federal securities fraud class action alleges that Cytokinetics' executives made misleading statements that caused significant harm to shareholders, potentially affecting the company's future financing capabilities.
- Legal Consequences: Shareholders who purchased shares before December 27, 2023, can seek court-approved incentive awards, highlighting potential flaws in corporate governance and legal risks.
Continue Reading
Holley Inc. Faces Shareholder Lawsuit Over Securities Fraud Allegations
- Shareholder Lawsuit Initiated: Current shareholders of Holley Inc. (NYSE: HLLY) can seek corporate reforms and fund returns, indicating significant legal challenges that may impact shareholder confidence and market performance.
- Fraud Allegations Survive: A federal securities fraud class action has survived a motion to dismiss, alleging that Holley executives failed to disclose deteriorating relationships with distributors, which could lead to declining sales and affect future revenues.
- Market Trust Crisis: Holley's excessive focus on its direct-to-consumer channel has damaged relationships with distributors, which are crucial for revenue, potentially resulting in market share loss and diminished competitive standing.
- Consequences of Integration Failure: Holley has failed to effectively integrate its acquisitions, leading to operational inefficiencies and inventory management issues, which exacerbate financial pressures and could hinder the company's long-term strategic growth.
Continue Reading